$15.50
0.140.91%
Last update: Nov 9, 4:21 PM
Ascentage Pharma Group International
AAPGNASDAQ
Ascentage Pharma Group International fell 52.2% from $32.40 to $15.50, behind the S&P 500's +10.0%. Its worst day was Mar 20 (−14.4%), and its low came Nov 2 at $13.56.
Nov 10, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Ascentage Pharma Group International closed at its highest level of the year, 5.9% above where the year started.
+2.6% · S&P 500 0.0%
EPS of $-0.50 was reported on $82.1M revenue (est. $83.0M).
Story events cover the past 12 months · Times ET
−6.4% · S&P 500 −1.8%
Ascentage Pharma Group International shares fell 11.5%, while the S&P 500 fell 0.4%.
−11.5% · S&P 500 −0.4%
Ascentage Pharma Group International shares rose 10.0%, while the S&P 500 rose 0.6%.
+10.0% · S&P 500 +0.6%
EPS of $-0.32 beat the $-0.44 estimate on $44.5M revenue (est. $24.1M).
−3.5% · S&P 500 −0.8%
Ascentage Pharma Group International shares rose 11.3%, while the S&P 500 rose 0.5%.
+11.3% · S&P 500 +0.5%
Ascentage Pharma Group International closed at its lowest level of the year, 58.1% below where the year started.
−3.8% · S&P 500 −0.5%
Where it ended: a close of $15.50 on Nov 10, 2026.
Nothing in the past 12 months.
All AAPG dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for AAPG and SPY from Benzinga historical bars. Not investment advice.
